ex vivo expanded autologous human corneal epithelial cells containing stem cells
As the list published 23 Sept 2026 has it, binding since 22 Apr 2026. Each entry binds six months after its own publication date (Article 107c(7) of Directive 2001/83/EC).
What the list says
- EU reference date
- 17 Feb 2015
- PSUR frequency
- 1 year
- Data lock point
- 17 Feb 2026
- Submission date
- 28 Apr 2026
- Next data lock point
- 17 Feb 2027
- Next submission date
- 28 Apr 2027
- Products covered
- Centrally authorised (CAP)
Are PSURs required for products referred to in Articles 10(1), 10a and 16a of Directive 2001/83/EC?
No — the list does not require PSURs for these products.
The list asks this as one question for Articles 10(1), 10a and 16a together, and does not answer it for Article 14 at all. A PSUR may in any case be required at the request of a competent authority or as a condition of the marketing authorisation.
Notes in the list
DLP was amended on 22/10/2025
Track dates like these for your own products: a sample workspace, read-only, no account needed.
Try the demoThe next three reports
- Data lock point 17 Feb 2027Submission by 28 Apr 2027
- Data lock point 17 Feb 2028Submission by 27 Apr 2028
- Data lock point 17 Feb 2029Submission by 28 Apr 2029
Counted from the data lock point the list gives, on the cycle it states: the submission date is 70 days after the data lock point — 70 days for a cycle of twelve months or less, 90 days for a longer one, as GVP Module VII sets out.
In earlier versions of the list
EMA/630645/2012 Rev.164 · published 23 Sept 2026
ex vivo expanded autologous human corneal epithelial cells containing stem cells — every 1 year, data lock point 17 Feb 2027
EMA/630645/2012 Rev.156 · published 4 Feb 2026
ex vivo expanded autologous human corneal epithelial cells containing stem cells — every 1 year, data lock point 17 Feb 2027
Source: European Medicines Agency, list of EU reference dates and frequency of submission of periodic safety update reports, EMA/630645/2012 Rev.164, published 23 Sept 2026. Open the published file
Kreastel is a planning and oversight aid for pharmacovigilance obligations. It tracks dates like these for a marketing authorisation holder's own products.
Report a discrepancy — if this page and the published file disagree, the file is right and we want to know.